Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 67/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed with results

Key Signals

75% success

Data Visualizations

Phase Distribution

2Total

P 3 (2)

Trial Status

Completed3

Terminated1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (4)

Showing 4 of 4 trials

NCT02734264CompletedPrimary

Field Studies of Amebiasis in Bangladesh

NCT00001162TerminatedPrimary

Parasitic Infections of the Gastrointestinal Tract

NCT00366236Phase 3CompletedPrimary

Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents

NCT00366730Phase 3CompletedPrimary

Study of Nitazoxanide in the Treatment of Amebiasis in Children

Showing all 4 trials

Amebiasis